347 Results

People

  1. Mauro
    Mauro
  2. Clarkson
    Clarkson
  3. Berman
    Berman
  4. O'Reilly
    O'Reilly
  5. Strife
    Strife
  6. Wisniewski
    Wisniewski
  7. Kernan
    Kernan
  8. Sawyers
    Sawyers
  9. Scheinberg
    Scheinberg
  10. Papadopoulos
    Papadopoulos

Groups

  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)
  7. Tow Center for Developmental Oncology (TCDO) (77)
  8. Molecular Pharmacology and Chemistry Program Faculty (71)
  9. Human Oncology and Pathogenesis Program (47)
  10. Pediatrics, Department of (46)
  1. "chronic myeloid leukemia"
Formats
  1. Journal Article (300)
  2. Meeting Abstract (18)
  3. Review (10)
  4. Conference Paper (8)
  5. Research Letter (6)
  6. Correspondence (2)
  7. Editorial (2)
  8. Guidelines (1)
Groups
  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)

More Groups

People
  1. Michael Mauro (56)
  2. Bayard Clarkson (40)
  3. Ellin Berman (24)
  4. Annabel Strife (20)
  5. Richard O'Reilly (20)
  6. David Wisniewski (18)

More People

Years
  1. 2025 (7)
  2. 2024 (16)
  3. 2023 (20)
  4. 2022 (13)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Blood (29)
  2. Leukemia (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (19)
  4. Biology of Blood and Marrow Transplantation (17)
  5. Bone Marrow Transplantation (15)
  6. Cancer Research (14)

More Publications

Publishers
  1. Elsevier Inc. (51)
  2. Nature Publishing Group (51)
  3. American Society of Hematology (33)
  4. American Association for Cancer Research (20)
  5. John Wiley & Sons (12)
  6. Springer (12)

More Publishers

Results (347)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
    Journal Article

    Barker, J. N.; Devlin, S. M.; Naputo, K. A.; Skinner, K.; Maloy, M. A.; Flynn, L.; Anagnostou, T.; Avecilla, S. T.; Scaradavou, A.; Cho, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of asciminib in heavily pretreated patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia in chronic phase (CML-CP) with sensitivity to tyrosine kinase inhibitors (TKIs)
    Meeting Abstract

    Hughes, T.; Mauro, M.; Kim, D. W.; Cortes, J.; Réa, D.; Minami, H.; Breccia, M.; DeAngelo, D.; Hochhaus, A.; Goh, Y. T.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Incidence of cardiovascular (CV)-related hospitalizations and associated costs among US patients with chronic-phase chronic myeloid leukemia (CP-CML) treated with first-line (1L) tyrosine kinase inhibitors (TKI) in SIMPLICITY: An observational study
    Meeting Abstract

    Goldberg, S. L.; Mauro, M.; Cortes, J.; Keating, S. J.; Bhandari, H.; Chen, C.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Interim analysis from the OPTIC trial - A dose-ranging study of 3 starting doses of ponatinib
    Meeting Abstract

    Cortes, J.; Lomaia, E.; Turkina, A.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Rojas, C.; Chuah, C.; Arthur, C.; Apperley, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Retrospective independent review of arterial occlusive events (AOEs) in the ponatinib phase 2 PACE trial (NCT01207440) in patients with Philadelphia chromosome positive (Ph+) leukemia
    Meeting Abstract

    Januzzi, J.; Garasic, J.; Kasner, S.; McDonald, V.; Petrie, M.; Seltzer, J.; Mauro, M.; Croce, K.; Berman, E.; Deininger, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Extracting and classifying diagnosis dates from clinical notes: A case study
    Journal Article

    Fu, J. T.; Sholle, E.; Krichevsky, S.; Scandura, J.; Campion, T. R.
    Journal of Biomedical Informatics (2020)

    Fulltext@MSK | Save
  • BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
    Journal Article

    Stanchina, M.; McKinnell, Z.; Park, J. H.; Stein, E. M.; Cai, S. F.; Taylor, J.
    Leukemia Research Reports (2020)

    Fulltext@MSK | Save
  • Cardiovascular mortality among chronic myeloid leukemia patients in the pre-tyrosine kinase inhibitor (TKI) and TKI eras: A surveillance, epidemiology and end results (SEER) analysis
    Journal Article

    Wang, Q.; Jiang, C.; Zhang, Y.; Zhang, Y.; Yue, B.; Zheng-Lin, B.; Zhao, Y.; Mauro, M. J.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Comparison of high doses of total body irradiation in myeloablative conditioning before hematopoietic cell transplantation
    Journal Article

    Sabloff, M.; Chhabra, S.; Wang, T.; Fretham, C.; Kekre, N.; Abraham, A.; Adekola, K.; Auletta, J. J.; Barker, C.; Beitinjaneh, A. M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Risk of disease progression in low-risk MDS is linked to distinct epigenetic subtypes - To the editor
    Research Letter

    Qin, T.; Sotzen, J.; Rampal, R. K.; Rapaport, F. T.; Levine, R. L.; Klimek, V.; Nimer, S. D.; Figueroa, M. E.
    Leukemia (2019)

    Fulltext@MSK | Save